Cargando…

Introduction

Mostrar otras versiones (3)

Detalles Bibliográficos
Autores principales:	Zhao, Peter, Samji, Tasleem, Carleton, Heather A.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	YJBM 2011
Materias:	Focus: Immunology and Immunotherapeutics
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3238308/ https://www.ncbi.nlm.nih.gov/pubmed/22282964

Ejemplares similares

Introduction
por: Carleton, Heather, et al.
Publicado: (2011)

Radioimmunotherapy of Non-Hodgkin’s Lymphoma: From the ‘Magic Bullets’ to ‘Radioactive Magic Bullets’
por: Chamarthy, Murthy R., et al.
Publicado: (2011)

Ipilimumab and Cancer Immunotherapy: A New Hope for Advanced Stage Melanoma
por: Mansh, Matthew
Publicado: (2011)

Regulating Caspase-1 During Infection: Roles of NLRs, AIM2, and ASC
por: Case, Christopher L.
Publicado: (2011)

Cancer Immunotherapy Takes a Multi-Faceted Approach to Kick the Immune System into Gear
por: Dimberu, Peniel M., et al.
Publicado: (2011)

Learning to Live Together: Harnessing Regulatory T cells to Induce Organ Transplant Tolerance
por: Chang, Andrew Y., et al.
Publicado: (2011)

Blockade of the B7-H1/PD-1 Pathway for Cancer Immunotherapy
por: Flies, Dallas B., et al.
Publicado: (2011)

Nanoparticle Delivery of Anti-Tuberculosis Chemotherapy as a Potential Mediator Against Drug-Resistant Tuberculosis
por: Smith, Jonathan Paul
Publicado: (2011)

Vaccination: The Present and the Future
por: Sadanand, Saheli
Publicado: (2011)

Introduction
por: Kunjappu, Mary J., et al.
Publicado: (2011)

Immunotherapy of glioblastoma: Recent advances and future prospects
por: Yuan, Boyang, et al.
Publicado: (2022)

The progress of peptide vaccine clinical trials in gynecologic oncology
por: Tang, Mi, et al.
Publicado: (2022)

Vaccines as a preventive tool for substance use disorder: A systematic review including a meta-analysis on nicotine vaccines’ immunogenicity
por: Scendoni, Roberto, et al.
Publicado: (2022)

Review of bimekizumab in the treatment of psoriasis
por: Koppu, Sindhuja, et al.
Publicado: (2022)

Therapeutic potential of mesenchymal stem cells for refractory inflammatory and immune skin diseases
por: Hua, Chunting, et al.
Publicado: (2022)

Current updates on generations, approvals, and clinical trials of CAR T-cell therapy
por: Asmamaw Dejenie, Tadesse, et al.
Publicado: (2022)

Immune checkpoint inhibitors in esophageal cancer: Clinical development and perspectives
por: Nagata, Yusuke, et al.
Publicado: (2022)

The employment of vaccinia virus for colorectal cancer treatment: A review of preclinical and clinical studies
por: Ling, Qiaoyun, et al.
Publicado: (2022)

Adoptive tumor infiltrating lymphocytes cell therapy for cervical cancer
por: Zhu, Yahui, et al.
Publicado: (2022)

Introduction
por: Samji, Tasleem
Publicado: (2010)

RSV-related hospitalization and outpatient palivizumab use in very preterm (born at <29 wGA) infants: 2003-2020
por: Packnett, Elizabeth R., et al.
Publicado: (2022)

Belimumab for systemic lupus erythematosus – Focus on lupus nephritis
por: Plüß, Marlene, et al.
Publicado: (2022)

Human placental hematopoietic stem cell derived natural killer cells (CYNK-001) mediate protection against influenza a viral infection
por: Gleason, Joseph, et al.
Publicado: (2022)

Long-term survival after immunotherapy and targeted therapy without chemotherapy in an elderly patient with HER2-positive gastroesophageal junction cancer: A case report
por: Li, Wei-Ling, et al.
Publicado: (2022)

PD-1 inhibitor treatment in a penile cancer patient with MMR/MSI status heterogeneity: A case report
por: Du, YunYi, et al.
Publicado: (2022)

Advancing humanized monoclonal antibody for counteracting fentanyl toxicity towards clinical development
por: Hicks, Dustin, et al.
Publicado: (2022)

Update about Oralair® as a treatment for grass pollen allergic rhinitis
por: Klimek, L., et al.
Publicado: (2022)

Development and evaluation of a tetravalent botulinum vaccine
por: Shi, Dan-Yang, et al.
Publicado: (2022)

Anti CD38 monoclonal antibodies for multiple myeloma treatment
por: Gozzetti, Alessandro, et al.
Publicado: (2022)

MicroRNA-873-5p suppresses cell malignant behaviors of thyroid cancer via targeting CXCL5 and regulating P53 pathway
por: Chang, Wang, et al.
Publicado: (2022)

Relationship between T-cell-dependent and T-cell-independent vaccines after neurotrauma; is the B-cell response preserved?
por: Ljunghill Hedberg, Anna, et al.
Publicado: (2022)

Efficacy and safety of immune checkpoint inhibitors in advanced pancreatic cancer: A real world study in Chinese cohort
por: Gong, Xiaoling, et al.
Publicado: (2022)

CIMT 2022: Report on the 19th Annual Meeting of the Association for Cancer Immunotherapy
por: Berger, Peer Andre, et al.
Publicado: (2022)

Waning of maternal antibody against measles virus in Shufu, China
por: He, Qing, et al.
Publicado: (2022)

Nanovaccines: Merits, and diverse roles in boosting antitumor immune responses
por: Yin, Qiliang, et al.
Publicado: (2022)

Near complete response to a pembrolizumab-based therapeutic strategy in an abdominal metastatic head and neck squamous cell carcinoma case
por: Wu, Taowei, et al.
Publicado: (2022)

Omalizumab added to allergen immunotherapy increased the effect of therapy in patients with severe local allergic rhinitis
por: Bozek, Andrzej, et al.
Publicado: (2022)

Expert consensus on the role of OM-85 in the management of recurrent respiratory infections: A Delphi study
por: Esposito, Susanna, et al.
Publicado: (2022)

Intravenous injection of a novel viral immunotherapy encoding human interleukin-7 in nonhuman primates is safe and increases absolute lymphocyte count
por: Coupet, Charles-Antoine, et al.
Publicado: (2022)

Vaccination with a shared oncogenic tumor-self antigen elicits a population of CD8+ T cells with a regulatory phenotype
por: Elizondo, C. Riccay, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_f06kodk53a1ne14i61fisii3hv